Novartis Deutschland GmbH

Oxford BioMedica Announces Lentiviral Vector Development and Manufacturing Collaboration

Oxford BioMedica plc announced that it has signed an agreement with Novartis to manufacture clinical grade material utilising Oxford BioMedica’s LentiVector® gene delivery technology.  Under the terms of the agreement, Oxford BioMedica will also provide certain process development services ... more

Evotec receives Milestone in Drug Discovery Collaboration

Evotec AG announced that it has received a pre-clinical milestone from its Drug Discovery Collaboration with Novartis. No financial details were given. Under the terms of the agreement, Evotec is responsible for progressing the program up to pre-clinical development and Novartis will then h ... more

Novartis and University of Pennsylvania form broad-based R&D alliance to advance novel T-cell immunotherapies to treat cancer

Novartis and the University of Pennsylvania (Penn) announced an exclusive global collaboration to research, develop and commercialize targeted chimeric antigen receptor (CAR) immunotherapies for the treatment of cancers. In addition, the parties will jointly establish a new research and dev ... more

Novartis Animal Health Inc.

We focus on the well-being of companion animals and the health and productivity of farm animals. Our extensive product range provides solutions for the prevention and treatment of various widespread animal diseases and parasite infestations. The majority of these products are available by p ... more

Novartis Austria GmbH

more

Novartis Deutschland GmbH

more

Novartis Research Foundation

more